Business Description
Neogen Corp
NAICS : 325412
SIC : 2835
ISIN : US6404911066
Share Class Description:
FRA:NG2: Ordinary SharesDescription
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.19 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | 4.94 | |||||
| Interest Coverage | 0.8 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.13 | |||||
| Beneish M-Score | -2.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.8 | |||||
| 3-Year EBITDA Growth Rate | -2.5 | |||||
| 3-Year Book Growth Rate | 22.9 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4.18 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 78 | |||||
| 9-Day RSI | 63.23 | |||||
| 14-Day RSI | 56.62 | |||||
| 6-1 Month Momentum % | 9.42 | |||||
| 12-1 Month Momentum % | -21.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.82 | |||||
| Quick Ratio | 2.59 | |||||
| Cash Ratio | 1.11 | |||||
| Days Inventory | 127.93 | |||||
| Days Sales Outstanding | 62.24 | |||||
| Days Payable | 71.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -26.3 | |||||
| Shareholder Yield % | 0.22 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.19 | |||||
| Operating Margin % | 6.35 | |||||
| Net Margin % | -1.02 | |||||
| FCF Margin % | -8.26 | |||||
| ROE % | -0.3 | |||||
| ROA % | -0.21 | |||||
| ROIC % | 0.91 | |||||
| 3-Year ROIIC % | -0.57 | |||||
| ROC (Joel Greenblatt) % | 12.04 | |||||
| ROCE % | 1.34 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 28.69 | |||||
| PE Ratio without NRI | 79.04 | |||||
| Shiller PE Ratio | 36.62 | |||||
| PS Ratio | 4.04 | |||||
| PB Ratio | 1.19 | |||||
| Price-to-Operating-Cash-Flow | 105.71 | |||||
| EV-to-EBIT | 75.37 | |||||
| EV-to-Forward-EBIT | 21.34 | |||||
| EV-to-EBITDA | 24.7 | |||||
| EV-to-Forward-EBITDA | 17.48 | |||||
| EV-to-Revenue | 4.82 | |||||
| EV-to-Forward-Revenue | 3.29 | |||||
| EV-to-FCF | -58.48 | |||||
| Price-to-Projected-FCF | 1.38 | |||||
| Price-to-Median-PS-Value | 0.56 | |||||
| Earnings Yield (Greenblatt) % | 1.33 | |||||
| FCF Yield % | -2.04 | |||||
| Forward Rate of Return (Yacktman) % | -1.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Neogen Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 853.301 | ||
| EPS (TTM) (€) | -0.041 | ||
| Beta | 1.44 | ||
| Volatility % | 53.71 | ||
| 14-Day RSI | 56.62 | ||
| 14-Day ATR (€) | 0.277347 | ||
| 20-Day SMA (€) | 14.53 | ||
| 12-1 Month Momentum % | -21.76 | ||
| 52-Week Range (€) | 10.7 - 18.8 | ||
| Shares Outstanding (Mil) | 216.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Neogen Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Neogen Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Neogen Corp Frequently Asked Questions
What is Neogen Corp(FRA:NG2)'s stock price today?
The current price of FRA:NG2 is €15.00. The 52 week high of FRA:NG2 is €18.80 and 52 week low is €10.70.
When is next earnings date of Neogen Corp(FRA:NG2)?
The next earnings date of Neogen Corp(FRA:NG2) is 2024-10-10 Est..
Does Neogen Corp(FRA:NG2) pay dividends? If so, how much?
Neogen Corp(FRA:NG2) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers